Impact of stage III-IV endometriosis on recipients of sibling oocytes: matched case-control study

Díaz I, I. Díaz, Israel Dı́az, Navarro J, J Navarro, L Blasco, Blasco L, José A. Navarro, Carlos Simón, Luis Blasco, C Simón, A Pellicer, Pellicer A, Remohí J, J Remohí, António Pellicer, J. Remohı́
Fertility and sterility · 2000 · vol. 74(1) , pp. 31–34 · doi:10.1016/s0015-0282(00)00570-7 · PMID:10899493 · W2019843041
Observational OA: closed CC0 ⤵ 161 in-corpus citations
View on OpenAlex View on PubMed View at publisher
⚙ AI-generated summary by gemini-2.5-flash-lite, 2026-06-07 ⓘ

This matched case-control study investigated the impact of stage III-IV endometriosis on recipients of sibling oocytes, comparing outcomes for women with and without this condition.

One-sentence paraphrase of the abstract; not a substitute for reading it. No clinical advice. How this works

Abstract

OBJECTIVE: To evaluate the impact of severe endometriosis on IVF-ET outcome in women receiving oocytes from the-same donor. DESIGN: A matched case-control study. SETTING: Oocyte donation program at the Instituto Valenciano de Infertilidad. PATIENT(S): Fifty-eight recipients were included in a matched case-control study of IVF-ET in our oocyte donation program. Twenty-five patients were diagnosed by laparoscopy with stage III-IV endometriosis (group I), while the remaining 33 were free of the disease (group II). On the day of retrieval, oocytes from a single donor were donated to recipients from both groups. Some of the donors supplied oocytes for more than 2 patients. Recipients received steroid replacement therapy for endometrial preparation. INTERVENTION(S): Ovarian stimulation and oocyte retrieval in donors. Uterine embryo transfer (ET) in recipients after appropriate exogenous hormone replacement therapy (HRT). MAIN OUTCOME MEASURE(S): Pregnancy, implantation, miscarriage, and live birth rates. RESULT(S): The number of oocytes donated and fertilized, as well as the number of available and transferred embryos, was not statistically different between the two groups. Pregnancy, implantation, and miscarriage rates were not affected by stage III-IV endometriosis when compared with the control group. The live birth rate was 28.0% in the group with endometriosis and 27.2% in the control group. CONCLUSION(S): These results show that implantation is not affected by stage III-IV endometriosis. Given the contemporary methods of endometrial preparation for transfer of embryos derived from donor oocytes, any potential negative effect of severe endometriosis on the uterine environment is undetectable.

My notes (saved in your browser only)

Condition tags

endometriosis

MeSH descriptors

Embryo Transfer Embryo Transfer Endometriosis Fertilization in Vitro Fertilization in Vitro Oocyte Donation Oocyte Donation Abortion, Spontaneous Abortion, Spontaneous Adult Adult Birth Rate Birth Rate Case-Control Studies Case-Control Studies Embryo Implantation Embryo Implantation Endometriosis Endometriosis Female

Citation neighborhood (2-hop)

Papers in the corpus that this work cites (lower rings, blue) and that cite this one (upper rings, green). Dot size scales with the paper's in-corpus citation count — bigger dot = more influential within the endo/adeno field. Click a dot to open that paper. Outer rings show 2-hop neighbours — papers reached through the immediate citers/citees. [ collapse to 1-hop ]

References (11)

Cited by (50)

Source provenance

europepmc
last seen: 2026-10-13T06:10:10.580696+00:00
openalex
last seen: 2026-06-10T17:14:06.276822+00:00
pubmed
last seen: 2026-10-08T20:59:30.381419+00:00
License: CC0 · commercial use OK